SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-025105
Filing Date
2024-06-25
Accepted
2024-06-25 16:32:47
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7111
  Complete submission text file 0001493152-24-025105.txt   8855
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2231 RUTHERFORD ROAD SUITE 200 CARLSBAD CA 92008
Business Address
Gurrola Sandra M (Reporting) CIK: 0001618457 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 241069365